WallStSmart
PPBT

Purple Biotech

NASDAQ: PPBT · HEALTHCARE · BIOTECHNOLOGY

$4.23
-6.90% today

Updated 2026-04-29

Market cap
$6.95M
P/E ratio
P/S ratio
58.08x
EPS (TTM)
$-54.00
Dividend yield
52W range
$4 – $29
Volume
0.0M

Purple Biotech (PPBT) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item2013201420152016201720182019202020212022202320242025
Revenue$100000.00$1.00M$1.00M$1.00M$-320000.00$-910000.00$195804.00$0.00$0.00
Revenue growth (YoY)+900.0%+0.0%+0.0%-132.0%-184.4%+121.5%-100.0%
Cost of revenue$80.00$58.00$55.00$120.00$196000.00$186000.00$204610.00
Gross profit$100000.00$1.00M$999920.00$999942.00$-55.00$-120.00$-196.00$-186000.00$-204610.00
Gross margin100.0%100.0%100.0%100.0%0.0%0.0%-0.1%
R&D$109000.00$3.19M$2.56M$4.18M$4.64M$5.27M$2.28M$7.49M$11.83M$16.32M$17.03M$7.62M$3.76M
SG&A$1.06M$1.27M$1.51M$3.00M$6.39M$5.19M$6.08M$5.71M$5.82M$5.96M$4.84M$2.94M$2.98M
Operating income$-2.55M$-5.18M$-4.07M$-7.18M$-11.97M$-7.83M$-7.16M$-13.24M$-17.93M$-22.60M$-22.27M$-11.01M$-7.03M
Operating margin-11966.0%-782.6%-715.6%-1323.9%5604.4%2483.8%-11374.1%
EBITDA$-1.20M$-5.23M$-4.20M$-7.04M$-12.88M$-5.55M$-6.14M$-28.41M$-17.52M$-21.49M$-19.88M$-7.05M$-6.83M
EBITDA margin-12883.0%-555.3%-613.6%-2841.0%5473.8%2361.8%-10150.5%
EBIT$-2.55M$-5.18M$-4.20M$-7.04M$-12.89M$-5.56M$-6.32M$-28.64M$-17.75M$-21.69M$-19.92M$-7.24M$-7.03M
Interest expense$48000.00$21000.00$3000.00$6000.00$26000.00$9000.00$181000.00$56000.00$212000.00$67000.00$2.18M$447000.00$989790.00
Income tax$-1.31M$50000.00$-76000.00$6000.00$-710000.00$207000.00$216000.00$-15.67M$637000.00$877000.00$-97000.00
Effective tax rate33.2%-1.0%1.8%-0.0%5.5%-4.1%-3.8%35.9%-3.6%-4.2%83.0%0.0%0.0%
Net income$-2.63M$-5.25M$-4.20M$-12.13M$-12.18M$-5.20M$-5.85M$-28.00M$-18.38M$-21.67M$-19880.00$-7.24M$-26.81M
Net income growth (YoY)-99.8%+20.0%-188.6%-0.4%+57.3%-12.5%-378.6%+34.3%-17.9%+99.9%-36318.5%-270.3%
Profit margin-12177.0%-520.0%-585.0%-2799.9%5745.0%2381.1%-10.2%